Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) (C-Term) Peptide

ERBB3 Reactivité: Humain Hôte: Synthetic BP
N° du produit ABIN8110151
168,15 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) (C-Term) Peptide (ABIN8110151)

Antigène

ERBB3 (Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3))

Origine

Humain

Source

  • 9
Synthetic

Application

Blocking Peptide (BP)
  • Protein Region

    C-Term

    Fonction

    ERBB3 Peptide - C-terminal region

    Séquence

    SASLGSTQSC PLHPVPIMPT AGTTPDEDYE YMNRQRDGGG PGGDYAAMGA
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    This is a synthetic peptide designed for use in combination with anti- ERBB3 Antibody (ARP83907_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Antigène

    ERBB3 (Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3))

    Sujet

    Background Information: This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized.

    Alternative Symbols: HER3, LCCS2, ErbB-3, c-erbB3, erbB3-S, MDA-BF-1, c-erbB-3, p180-ErbB3, p45-sErbB3, p85-sErbB3

    Poids moléculaire

    76 kDa

    ID gène

    2065

    NCBI Accession

    NP_001005915

    UniProt

    P21860
Vous êtes ici:
Chat with us!